Buscar
Elementos (mostrados por Fecha de envío en Descendente orden): 1 a 5 de 5
Elementos (mostrados por Fecha de envío en Descendente orden): 1 a 5 de 5
Envíos recientes
Omalizumab, the innovative biologic that disrupted the market of the treatment of allergic diseases
Characterization of potential therapeutic targets in Leishmania infantum
Development of G9a-targeted BioPROTACs based on peptides and nanobodies
Empleo de endolisinas frente a Gram-negativos